Examining Medication Persistence Methods and Outcomes in Patients Post MI
Understanding medication persistence post myocardial infarction (MI) is crucial for optimizing patient outcomes. The ARTEMIS trial explored variation in P2Y12 inhibitor persistence rates using multiple measurement methods. This study design involved over 11,000 MI patients across 301 US hospitals, w
5 views • 12 slides
Discordance Between GH and IGF-1 in Acromegaly: Insights and Recommendations
Acromegaly, a rare disease driven by excess growth hormone secretion, often presents with discordant GH and IGF-1 levels post-treatment, challenging remission confirmation. Guidelines stress the importance of post-treatment biochemical marker evaluation, recommending specific thresholds for IGF-1 an
0 views • 37 slides